Cargando…

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease

Detalles Bibliográficos
Autores principales:	Tyc, Olaf, Jansen, Christian, Schierwagen, Robert, Uschner, Frank Erhard, Israelsen, Mads, Klein, Sabine, Ortiz, Cristina, Strassburg, Christian P., Zeuzem, Stefan, Gu, Wenyi, Torres, Sandra, Praktiknjo, Michael, Kersting, Stephan, Langheinrich, Melanie, Nattermann, Jacob, Servant, Florence, Arumugam, Manimozhiyan, Krag, Aleksander, Lelouvier, Benjamin, Weismüller, Tobias J., Trebicka, Jonel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letters from the Frontline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462439/ https://www.ncbi.nlm.nih.gov/pubmed/32885580 http://dx.doi.org/10.1002/lt.25882

Ejemplares similares

Trust is good, control is better: technical considerations in blood microbiome analysis
por: Schierwagen, Robert, et al.
Publicado: (2020)

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS
por: Queck, Alexander, et al.
Publicado: (2020)

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2021)

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
por: Madsen, Bjørn Stæhr, et al.
Publicado: (2018)

Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis
por: Alvarez-Silva, Camila, et al.
Publicado: (2019)

Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension
por: Klein, Sabine, et al.
Publicado: (2016)

β-Arrestin2 is increased in liver fibrosis in humans and rodents
por: Schierwagen, Robert, et al.
Publicado: (2020)

Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2018)

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
por: Queck, Alexander, et al.
Publicado: (2019)

Microbiome Patterns in Matched Bile, Duodenal, Pancreatic Tumor Tissue, Drainage, and Stool Samples: Association with Preoperative Stenting and Postoperative Pancreatic Fistula Development
por: Langheinrich, Melanie, et al.
Publicado: (2020)

Role of circulating angiogenin levels in portal hypertension and TIPS
por: Queck, Alexander, et al.
Publicado: (2021)

Left Ventricular Longitudinal Contractility Predicts Acute‐on‐Chronic Liver Failure Development and Mortality After Transjugular Intrahepatic Portosystemic Shunt
por: Jansen, Christian, et al.
Publicado: (2019)

Colon Cancer Microbiome Landscaping: Differences in Right- and Left-Sided Colon Cancer and a Tumor Microbiome-Ileal Microbiome Association
por: Kneis, Barbara, et al.
Publicado: (2023)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
por: Torp, Nikolaj, et al.
Publicado: (2021)

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
por: Torp, Nikolaj, et al.
Publicado: (2021)

The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver Disease
por: Schierwagen, Robert, et al.
Publicado: (2020)

Myostatin is associated with the presence and development of acute-on-chronic liver failure
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2023)

Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation
por: Casey, Stephen, et al.
Publicado: (2019)

Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats
por: Cremonese, Carla, et al.
Publicado: (2020)

Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
por: Klein, Sabine, et al.
Publicado: (2015)

Etiology and Complications of Portal Vein Thrombosis
por: Trebicka, Jonel, et al.
Publicado: (2014)

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
por: Torres, Sandra, et al.
Publicado: (2023)

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
por: Wang, Jin, et al.
Publicado: (2020)

Rapid COVID-19 Testing and On-site Case Investigation and Contact Tracing in an Underresourced Area of Salt Lake City, Utah, December 2020–April 2021
por: Gillwald, Karsten, et al.
Publicado: (2022)

Centralized COVID-19 Contact Tracing in a Home-Rule State
por: Macomber, Kathryn, et al.
Publicado: (2022)

Using Automation, Prioritization, and Collaboration to Manage a COVID-19 Case Surge in Maricopa County, Arizona, 2020
por: Scott, Sarah E., et al.
Publicado: (2022)

Community-Based Workforce for COVID-19 Contact Tracing and Prevention Activities in New York City, July–December 2020
por: Udeagu, Chi-Chi N., et al.
Publicado: (2022)

Unified Response to COVID-19 Case Investigation and Contact Tracing, Chicago, December 2020–April 2021
por: Kern, David, et al.
Publicado: (2022)

A University-Led Contact Tracing Program Response to a COVID-19 Outbreak Among Students in Georgia, February–March 2021
por: Harrington, Kristin R.V., et al.
Publicado: (2022)

The Role of miRNA-34a as a Prognostic Biomarker for Cirrhotic Patients with Portal Hypertension Receiving TIPS
por: Jansen, Christian, et al.
Publicado: (2014)

Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis
por: Görtzen, Jan, et al.
Publicado: (2015)

High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal
por: Kjærgaard, Maria, et al.
Publicado: (2017)

Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis
por: Queck, Alexander, et al.
Publicado: (2020)

Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma
por: Praktiknjo, Michael, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
por: Schierwagen, Robert, et al.
Publicado: (2020)

Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats
por: Klein, Sabine, et al.
Publicado: (2019)

MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitis
por: Lutz, Philipp, et al.
Publicado: (2017)

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
por: Israelsen, Mads, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0tlprc0aao8prnnpgl7farespm